manag patient myelodysplast syndrom myelodysplast syndrom group clonal hematolog neoplasm cours ineffect hematopoiesi leukem transform therapeut result past patient support measur transfus erythrocyt administr antibiot transfus platelet activ bleed episod support measur qualiti life patient myelodysplast syndrom vitamin supplement folat vitamin pyridoxin differenti agent cis-retino acid benefit limit number patient androgen use danazol attenu androgen effect subset patient presenc cell-bound platelet antibodi low-dos cytarabin differenti activ vitro low rate complet remiss substanti toxic antileukem therapi use young patient progress diseas sever hematopoiet growth factor clinic trial use combin conjunct chemotherapi new horizon patient improv prevent treatment graft-versus-host diseas allogen transplant viabl option patient year age sever cytopenia 